CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Key Biotech Applications In Agriculture

Key Biotech Applications In Agriculture

Here's The List Of Top Biotech Stocks To Buy In 2022

Here's The List Of Top Biotech Stocks...

How Does Biotechnology Help Humans?

How Does Biotechnology Help Humans?

How Does Biotechnology Help Agriculture Sector Reap Benefits

How Does Biotechnology Help...

Tryp Therapeutics Breaks New Grounds in Investigational Drugs

Tryp Therapeutics Breaks New Grounds...

Biotechnology in Agriculture: Key Applications and Significance to Know

Biotechnology in Agriculture: Key...

DNA Sequencing Everything You Need to Know

DNA Sequencing Everything You Need to...

The Applications of Data Analytics in Biotechnology

The Applications of Data Analytics in...

Key Biotech Applications In Agriculture

Key Biotech Applications In Agriculture

Here's The List Of Top Biotech Stocks To Buy In 2022

Here's The List Of Top Biotech Stocks...

How Does Biotechnology Help Humans?

How Does Biotechnology Help Humans?

How Does Biotechnology Help Agriculture Sector Reap Benefits

How Does Biotechnology Help...

Tryp Therapeutics Breaks New Grounds in Investigational Drugs

Tryp Therapeutics Breaks New Grounds...

Biotechnology in Agriculture: Key Applications and Significance to Know

Biotechnology in Agriculture: Key...

DNA Sequencing Everything You Need to Know

DNA Sequencing Everything You Need to...

The Applications of Data Analytics in Biotechnology

The Applications of Data Analytics in...

Rani Therapeutics Welcomes Eric Groen as General Counsel

Life Sciences Review Life Sciences Review | Tuesday, September 21, 2021
Tweet

Rani Therapeutics Holdings, a clinical-stage biotherapeutics firm focusing on creating technologies to develop orally delivered biologics, named Eric Groen as the General Counsel.


FREMONT, CA: Eric Groen has been named General Counsel at Rani Therapeutics Holdings, Inc., a clinical-stage biotherapeutics firm focusing on creating technologies to develop orally delivered biologics. Mr. Groen has over 25 years of experience in managing legal affairs in business and private practice.


Mr. Groen has a track record of working in the biopharmaceutical business as a lawyer. Before joining Rani, Mr. Groen worked at Amgen for approximately 20 years in various domestic and international roles with increasing responsibilities, such as heading legal teams responsible for business development deals, operations and manufacturing, and clinical trials. He was recently the regional general counsel for Amgen's commercial operations in Canada, Latin America, the Middle East, and Africa. Mr. Groen started his legal career at the TroyGould law firm, where he focused on corporate finance, securities compliance, corporate governance, and mergers and acquisitions. Mr. Groen graduated from Harvard Law School with a J.D. and UC Santa Barbara with a B.A. in Political Science.


"Eric is an accomplished executive whose legal expertise and business acumen have enabled him to handle complex legal matters across the breadth of biopharmaceutical operations, from R&D to manufacturing to commercial, with particular expertise in leading biopharmaceutical transactions. We look forward to his contributions as we continue to progress the RaniPillTM capsule technology and advance our clinical pipeline," said Talat Imran, Ranis Chief Executive Officer. "I am thrilled to welcome Eric to our team as we pursue our goal of making oral biologics a reality so that we may be able to help millions of people suffering from chronic diseases."


Rani Therapeutics is a clinical-stage biotherapeutics firm focusing on developing methods that would allow orally delivered biologics to be developed. The RaniPill capsule is a revolutionary, proprietary, and patented platform technology created by Rani to substitute subcutaneous injection of biologics with oral dosage. By using the RaniPill capsule, Rani has undertaken various preclinical and clinical trials to assess safety, tolerability, and bioavailability.


Weekly Brief

loading
Top 10 Leading BioTech Solution Companies - 2021
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue

Read Also

Hepion Pharmaceuticals to Get a Total of $ 3.2 Million in Non-Dilutive Financing

Benefits that Medical Writing Offers

Antibodies: Immunoglobulin Isotypes

Life Science Consulting Services Trends

Rani Therapeutics and Celltrion Partner to Develop Oral Monoclonal Antibodies

ProPhase Labs Acquires BE-Smart Esophageal Pre-Cancer Screening Test

The Influence of Pharmaceutical Distributors on U.S. Drug Expenditures

Tips to Improve Medical Writing

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/rani-therapeutics-welcomes-eric-groen-as-general-counsel-nwid-566.html